Form 424B3 Pulmatrix, Inc.
http://archive.fast-edgar.com/20250509/AB2ZI22CZC22G2LZ2H2Q2C42HMWSZC22Z272
Filed on: May 9, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stellantis Unveils Six Concept Cars “The Night Before” the Paris Motor Show
- New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
- Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!




Tweet
Share